ClinicalTrials.gg
RecruitingNCT06375681Updated Nov 12, 2026

Effectiveness of Cognitive Training in Older and Younger Adults

An interventional study of Visual and / or Auditory Cognitive Tasks (1) and Visual and / or Auditory Cognitive Tasks (2) in Cognitive Change, sponsored by University of Wisconsin, Madison. Recruiting at 3 sites in United States. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Nov 12, 2026Eligibility revisedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,600
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The proposed study will enroll 1600 participants to examine the effectiveness of cognitive training. Participants will be randomized into different experimental groups and can expect to participate for up to 15 hours of research over 4 to 8 weeks.

Read the detailed description

Participants will first complete two sessions (\~75 minutes each) where they are asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers. They will be asked to make some simple judgments about the stimuli (such as indicating whether the stimulus you observed is the same or different from that on a previous trial), and indicate their judgment decision with a button press on a keyboard, a mouse click, or a movement on a touchpad. They will also be asked to complete a set of questionnaires.

After the initial sessions, participants may be asked to complete two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab. Each set of sessions should be completed over a period of no more than 15 days. If asked to do these sessions, instructions will be given regarding the tasks to complete in these training sessions (which will be similar to some of the tasks you complete in the first two sessions, \~20 minutes) prior to these sessions.

After completing the first set of 10 sessions, participants will complete, either at home or in the lab, one session (\~75 minutes) of tasks similar to the first sessions. Participants who were not asked to complete the 20-minute sessions will complete another session two weeks after the first two 75-minute sessions in the same location as they completed the two 75-minute sessions.

Then, participants will complete the second set of ten 20-minute sessions, or wait for about two weeks for those not asked to complete the 20-minute sessions of cognitive tasks. After this, participants will complete two other sessions (\~75 minutes) in the same location as they completed the previous two 75-mintue sessions.

Finally, after a couple of weeks, participants will complete their two final testing sessions (\~45 minutes each) in the same location as they completed the previous two 75-mintue sessions.

The total duration of the study will be around 8 hours if not asked to complete the twenty 20-minute sessions, or 15 hours if asked to complete these sessions. The whole experiment runs over the course of 4 to 8 weeks.

*To maintain scientific integrity, certain details of this study will not be shared until all data has been collected.

02

Conditions studied

  • Cognitive Change

Keywords

  • Cognitive Training
  • Training task
  • Testing context
03

In context

Lead sponsor

University of Wisconsin, Madison is the lead sponsor of 1,190 studies on the registry; 181 are open to participants now.

Of its 157 completed or terminated interventional studies of FDA-regulated products, 118 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 12, 2026. See what changed

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Self-reported normal or corrected-to-normal vision
  • No known neurological impairments
  • Age within inclusion range (18-30 Years for Younger Adults and 60-85 Years for Older Adults)

Exclusion criteria

Exclusion Criteria

  • Physical handicap (motor or perceptual) that would impede training procedures
  • Vision that cannot be corrected to 20/20
  • Neurological impairments
  • Concurrent enrollment in other cognitive training studies
  • Previous enrollment in present study
  • Not being proficient enough in English that would prevent following and understanding all instructions and completing all testing sessions (typically, participants would need to have learned English before age 11; there might be some exceptions that will be decided on a case-by-case basis).
  • Unable to adhere to training schedule
  • Unable or unwilling to complete required tasks with full effort

Additional exclusion criteria for older adults:

- Score \< 17 (out of 22) on the Telephone (T-MoCA).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
1,600 participants (estimated)

Study arms

  • Active comparator
    Short Testing Group

    Participants will go through 2 assessment sessions over 2-3 days (\~75 minutes each), followed by 1 session of 75 minutes about 2 weeks later, 2 further sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.

    Behavioral: Visual and / or Auditory Cognitive Tasks (1)

  • Active comparator
    Long Testing Group

    Participants will go through 2 assessment sessions over 2-3 days (75 minutes each), followed by 10 sessions of cognitive tasks over 2 weeks, 1 session of 75 minutes about 2 weeks later, another 10 sessions of cognitive tasks over 2 weeks, then 2 sessions (\~75 minutes) over 2-3 days about 2 weeks after this session, and finally another 2 sessions (\~45 minutes) 3 days to 2 weeks after that session. Sessions might take place either at home or in the lab.

    Behavioral: Visual and / or Auditory Cognitive Tasks (1) · Behavioral: Visual and / or Auditory Cognitive Tasks (2)

Interventions

  • BehavioralVisual and / or Auditory Cognitive Tasks (1)

    Seven sessions (\~45-75 minutes) of cognitive tasks in the lab. Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

  • BehavioralVisual and / or Auditory Cognitive Tasks (2)

    Two sets of 10 sessions (\~20 minutes) of cognitive tasks either at home or in the lab. Participants asked to view visual stimuli (such as black and white lines, letters, simple shapes like triangles, circles, and squares) presented on a computer or television screen and/or listen to auditory stimuli (such as pure tones) presented via headphone or speakers and asked to make simple judgements.

06

What researchers measure

Primary outcomes

  1. Change in the difference between the proportion of hits minus false alarms for a given level of the N-back task

    The n-Back Task is a measure of working memory. The participant is sequentially shown a series of letters and is asked to indicate whether the current letter matches the letter presented "n" items before. The n levels range between 1- and 4-back. Each level of n-back has 17-19 letters, with 5 target letters.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  2. Change in the proportion of correctly reported sequences in the Corsi Complex task

    The Corsi Complex Task is a measure of working memory. The participant is sequentially shown a series of positions from 12 possible predefined spots on the screen. Between each position, the participants is also asked to categorize a stimulus between two categories based on color and shape. The participant's task is to report the sequence of positions in order. The length of sequence can vary between 2 and 10.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  3. Change in the proportion of correctly reported number and letter sets in the Letter-Number task

    The Letter-Number Sequence Task is a measure of working memory. In each trial, the participant is presented with a sequence of alternating letters and numbers, from 2 to 10 stimuli. Participants have to report the numbers in ascending order, and the letters in alphabetical order.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  4. Change in the difference of response time and accuracy in switch trials minus non-switch trials in the Task Switching Task

    The Task Switching task is a measure of cognitive flexibility. On each trial, participants view a letter and a digit. A cue tells the participant to either categorize the letter as a consonant or vowel or else categorize the digit as even or odd. Trials can be either "non-switch trials" - in which the participant is asked to perform the same task as on the previous trial - or "switch trials" - in which the participant is asked to perform the opposite task as on the previous trial. The participant will complete 48 trials. A "switch cost" is calculated by subtracting the average response time for switch trials from the average response time for non-switch trials.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  5. Change in the difference of response time in (i) switch trials minus non-switch trials and (ii) congruent minus incongruent trials in the Flanker Task

    In the Flanker task, the participant is asked to indicate whether the centrally presented arrow is pointing either to the left or right by pressing the left or right triangular buttons. This arrow is surrounded by 4 identical arrows, 2 to its left and 2 to its right; these are called non-target arrows. The participant is presented with two different trial types during the task, incongruent and congruent. In the congruent trials, the non-target arrows point in the same direction as the target arrow (e.g. all to the left) and in the incongruent trials they point in the opposite direction (e.g. target to the right, non-targets to the left). Switch trials are trials preceded by a trial of the opposite category (i.e. congruent preceded by incongruent or incongruent preceded by congruent).

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  6. Change in the proportion of correctly identified targets in the mixed condition of the Cancellation task

    The Cancellation task is a measure of cognitive flexibility. Participants are presented with rows of 8 stimuli that can be either cats or dogs. Each cat and dog varies along its orientation, color pattern, and/or stance, giving 4 distinct cats and 4 distinct dogs. One cat and one dog are targets, and the rest are distractors. The goal of the participant is to mark as many targets as possible within each row in the allotted time (210 seconds).

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  7. Change in the proportion of correct responses on the Useful Field of View (UFOV) Task

    The UFOV is a measure of visual selective attention. Participants are briefly presented with a display consisting of 24 peripheral items (3 on each of the four radial spokes and the four obliques; evenly spaced) and 1 central stimulus (a smiley with either long or short hair). One of the peripheral items is a target, while the remaining items are distractors. The participants' task is to indicate upon which of the 8 spokes the target appeared, and whether the central smiley had short or long hair. The display times vary between 16-500ms.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  8. Change in the proportion of correct responses on the Multiple Object Tracking (MOT) Task

    The MOT is a measure of visual divided attention. On each trial, participants view a series of blue and yellow smiley faces randomly moving in circular area. After a few seconds, the blue faces become yellow, indistinguishable from the distractors, while all the items keep moving on the screen. After another period of a few seconds, the items stop, and the participant is asked whether a randomly selected face was initially blue or yellow at the beginning of the trial.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  9. Change in the response time and percentage of correct responses in the Mental Rotation Task

    The mental rotation task is a measure of spatial cognition. Each trial displays two 2-D images, and the participant is asked whether the image on the right is a rotated version or a mirror-reserved and rotated version of the image on the left. The participant will complete 36 trials.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  10. Change in the percentage of correct responses in the Paper Folding task

    The Paper Folding task is a measure of mental rotation. Participants are shown 2-4 images depicting a piece of paper being folded with a hole being punched after the last fold. The participant is asked to imagine and indicate what the paper would look like unfolded. The participant will complete 10 trials.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  11. Change in the sum of correctly solved items in Raven's Advanced Progressive Matrices task

    Raven's Advanced Progressive Matrices task is a measure of fluid intelligence. The participant is presented with a grid of elements with one of the elements missing and is asked to identify the missing element that completes the grid pattern. The participant will complete 14 trials.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  12. Change in the sum of correctly solved items in the UC Matrix Reasoning task

    The UC Matrix Reasoning task is a measure of fluid intelligence. The participant is presented with a grid of elements with one of the elements missing and is asked to identify the missing element that completes the grid pattern. The participant will complete 16 trials.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  13. Change in the percentage of accuracy in the Shipley Institute of Living Scale

    Participants will complete Part I of the Shipley Institute of Living Scale, which is a measure of vocabulary. Participants are asked to select the appropriate synonym for a target word among several alternatives for 15 words.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

  14. Change in the percentage of accuracy in the Mill-Hill Vocabulary Scale

    In this vocabulary task, participants are asked to select the appropriate synonym for a target word among several alternatives for 25 words.

    Time frame: Pre-test (baseline), post-test1 up to 30 days, (unmasked) post-test2 up to 60 days

Secondary outcomes

  1. Big-5-Inventory 10-item version (BFI-10) Score

    Individual differences in personality moderating the potential link between expectations and performance on the battery of cognitive tasks. BFI-10 measures the individuals' personality traits: conscientiousness, agreeableness, neuroticism, openness to experience, and extraversion. The total possible range of scores is from 1-5 for each personality traits, where higher scores indicate higher expression of this personality trait.

    Time frame: Pre-Test

  2. Behavioral Inhibition/Activation System (BIS/BAS) Score

    Individual differences in reward sensitiveness moderating the potential link between expectations and performance on the battery of cognitive tasks. BIS/BAS measures the sensitivity to reward through four components, one inhibition component (punishment sensitivity) and three activation components (fun seeking, reward responsiveness, and drive). The total possible range of scores is from 1-4, where higher scores indicate higher expression of each dimension of the questionnaire.

    Time frame: Pre-Test

  3. Grit and Conscientiousness Score

    Individual differences in grit and conscientiousness moderating the potential link between expectations and performance on the battery of cognitive tasks. Grit and Consciousness measures the tendency to sustain effort toward long-term goals. The total possible range of scores is from 1-5, where higher scores indicate higher levels of grit and conscientiousness.

    Time frame: Pre-Test

  4. Meta-Cognition Score

    Individual differences in meta-cognitive skills moderating the potential link between expectations and performance on the battery of cognitive tasks. Meta-Cognition measures the ability to understand one's own abilities, strengths, and weaknesses. The total possible range of scores is from 1-5, where higher scores indicate higher meta-cognitive skills.

    Time frame: Pre-Test

  5. Theories of Intelligence - Mindset (Fixed vs Growth) Score

    Individual differences in mindset moderating the potential link between expectations and performance on the battery of cognitive tasks. Theories of Intelligence - Mindset (Fixed vs Growth) measures the extent to which the participants believe that intelligence is fixed or malleable. The total possible range of scores is from 1-4, where higher scores indicate a stronger endorsement of the growth mindset than a fixed mindset, and lower scores a stronger endorsement of the fixed mindset than a growth mindset.

    Time frame: Pre-Test

  6. Schutte self-report emotional intelligence test (SSEIT) Score

    Individual differences in emotional intelligence moderating the potential link between expectations and performance on the battery of cognitive tasks. SSEIT measures the ability to know and understand both one's own emotions and the emotions of others. The total possible range of scores is from 1-5, where higher scores indicate higher emotional intelligence.

    Time frame: Pre-Test

  7. Work and Family Orientation (WOFO) Score

    Individual differences in achievement motivation moderating the potential link between expectations and performance on the battery of cognitive tasks. WOFO is a measure the achievement motivation of participants on three separate scales: one for work (positive attitudes toward hard work), one for general mastery (preference for difficult, challenging tasks), and one for competitiveness. The total possible range of scores is from 1-5 for each dimension of the questionnaire, where higher scores indicate more positive attitudes toward hard work, higher preference for difficult, challenging tasks, and higher competitiveness respectively.

    Time frame: Pre-Test

  8. Brief Pittsburgh Sleep Quality Index (B-PSQI) Score

    Individual differences in sleep quality moderating the potential link between expectations and performance on the battery of cognitive tasks. B-PSQI is a measure the overall sleep quality of participants. The total possible range of scores is from 0-15, where higher scores indicate worse sleep quality.

    Time frame: Pre-Test

  9. Participant Experience Measure 1

    Measure will be scored from 0-5 and will be revealed when participant data collection is completed.

    Time frame: End of Post-Test (up to 60 days)

  10. Participant Experience Measure 2

    Measure will be scored from 0-5 and will be revealed when participant data collection is completed.

    Time frame: End of Post-Test (up to 60 days)

  11. Participant Experience Measure 3

    Measure will be scored from 0-5 and will be revealed when participant data collection is completed.

    Time frame: End of Post-Test (up to 60 days)

  12. Participant Experience Measure 4

    Measure will be scored from 0-5 and will be revealed when participant data collection is completed.

    Time frame: Beginning of Post-Test (up to 60 days)

  13. Participant Experience Measure 5

    Measure will be scored from 0-7 and will be revealed when participant data collection is completed.

    Time frame: Beginning of Post-Test (up to 60 days)

07

Study locations

3 of 3 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — All individual participant data (anonymized).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Data will be available persistently at the conclusion of the study.

Access criteria: There are no access criteria.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Apr 2025 (actual). Primary completion is estimated for May 2027, 25 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 16, 2024
First posted
Apr 19, 2024
StartActual
Apr 1, 2025
Primary completionEst.
May 2027
CompletionEst.
Jul 2027
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
4 exclusion criteria added
What changed in the criteria
Exclusion criteria
  • AddedVision that cannot be corrected to 20/20
  • AddedNeurological impairments
  • AddedPrevious enrollment in present study
  • AddedUnable or unwilling to complete required tasks with full effort
Nov 12, 2026
Show all 1 update
  1. Nov 12, 2026
    Eligibility 4 exclusion criteria added
    What changed in the criteria
    Exclusion criteria
    • AddedVision that cannot be corrected to 20/20
    • AddedNeurological impairments
    • AddedPrevious enrollment in present study
    • AddedUnable or unwilling to complete required tasks with full effort
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06375681
Responsible party
Sponsor
First posted
Apr 19, 2024
Start date
Apr 1, 2025
Primary completion
May 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Nov 12, 2026

Study contacts

C. Shawn Green, PhD
Contact
cshawn.green@wisc.edu
(608) 263-4868
Freya Joessel, PhD
Contact
joessel@wisc.edu
Aaron R. Seitz, PhD
principal investigator · University of California, Riverside
Susanne M. Jaeggi, PhD
principal investigator · Northeastern University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion